Polymer Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Polymer Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,872	Closed	-$533K	–	708
2026 Q1	$533K	Buy	+24,872	New	+$350K	0.05%	395
2025 Q4	–	Sell	-19,036	Closed	-$134K	–	812
2025 Q3	$134K	Buy	+19,036	New	+$131K	0.01%	720

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Polymer Capital Management's DAWN Position: Q2 2026 in Review

Polymer Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 24,872 shares — an estimated $533K sold.

Polymer Capital Management first reported a position in DAWN in Q3 2025 and held it in 2 quarters. The position peaked at $533K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Polymer Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Polymer Capital Management sold 24,872 Day One Biopharmaceuticals shares in Q2 2026, an estimated $533K.
Polymer Capital Management first reported a position in Day One Biopharmaceuticals in Q3 2025 and held it in 2 quarters.
Polymer Capital Management's Day One Biopharmaceuticals position peaked at $533K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.